CD274 and neoplasm: Applying the same strategy, a PD-L1 B cell peptide vaccine (PDL1-Vaxx) was also constructed and in combination with a dual Her-2 B cell vaccine (B-Vaxx) was recently shown to induce potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models [161].